The number of people with susceptibility test result for rifampicin in Austria
Austria: The number of people with susceptibility test result for rifampicin was 86.84 in 2021. ▬ Flat
Latest (2021)
86.84
Change on year
down 0.1%
World rank
80th
of 146 countries
All-time high
89.66
in 2018
All-time low
86.84
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Austria, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Austria is 86.84, measured in 2021. That is the lowest value across all 5 years on record.
The figure is down 0.1% on the previous year and down 2.9% over five years.
Austria ranks 80th of 146 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Austria, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 89.42 | — |
| 2018 | 89.66 | +0.3% |
| 2019 | 87.27 | -2.7% |
| 2020 | 86.93 | -0.4% |
| 2021 | 86.84 | -0.1% |
Austria compared with similar countries
- Austria's 86.84 is below the median for high income countries, which is 92.6, 94% of the median. (56 countries reporting)
- Austria's 86.84 is below the median for Europe & Central Asia, which is 93.52, 93% of the median. (43 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 88.78 | 87.27 | 89.66 | 3 |
| 2020s | 86.89 | 86.84 | 86.93 | 2 |
Countries ranked near Austria
- 77 Türkiye 87.71 compare
- 78 Dominican Republic 87.56 compare
- 79 Switzerland 87.3 compare
- 81 Belgium 86.27 compare
- 82 Netherlands 86.26 compare
- 83 Finland 86.14 compare
More health data for Austria
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -1.05 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,266 deaths per 1,000 people (2090)
- Number of infants who die before age 1 27 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.92 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0217 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.86 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Austria?
- The number of people with susceptibility test result for rifampicin in Austria was 86.84 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Austria?
- The highest recorded value was 89.66 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Austria?
- The lowest recorded value was 86.84 in 2021.
- How does Austria rank for the number of people with susceptibility test result for rifampicin?
- Austria ranks 80th out of 146 countries with data for 2021.
- Where does this Austria data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).